Differences in SARS-COV-2 seroprevalence in the population of Cusco, Peru

  • Charles Huamaní
  • , Fátima Concha-Velasco
  • , Lucio Velásquez
  • , María K. Antich
  • , Johar Cassa
  • , Kevin Palacios
  • , Luz Bernable-Villasante
  • , Guido Giraldo-Alencastre
  • , Eduarda Benites-Calderon
  • , Sebastian Mendieta-Nuñez
  • , Heber Quispe-Jihuallanca
  • , Matilde Quispe-Yana
  • , Karla Zavala-Vargas
  • , Liesbeth Hinojosa-Florez
  • , Javier Ramírez-Escobar
  • , Juan Spelucin-Runciman
  • , Antonio Bernabe-Ortiz

Producción científica: Artículo CientíficoArtículo originalrevisión exhaustiva

3 Citas (Scopus)

Resumen

Background: The spread of the coronavirus disease 2019 (COVID-19) in Peru has been reported at the regional level, few studies have evaluated its spread at the provincial level, in which the mechanisms could be different. Methods: We conducted an analytical, cross-sectional, multistage observational population study to assess the seroprevalence of SARS-COV-2 at the provincial and urban/rural levels in a high-altitude setting. The sampling unit was the household, including a randomly selected family member. Sampling was performed using a data collection sheet on clinical and epidemiological variables. Chemiluminescence tests were used to detect total anti-SARS-COV-2 antibodies (IgG and IgM simultaneously). The percentages were adjusted to the sampling design. Results: The overall prevalence in the region of Cusco was 25.9%, with considerably different prevalence between the 13 provinces (from 15.9% in Acomayo to 40.1% in Canchis) and between rural (21.1%) and urban (31.7%) areas. In multivariable model, living in a rural area was a protective factor (adjusted prevalence ratio [aPR], 0.68; 95% confidence interval [CI], 0.61–0.76). Conclusions: Geographic diversity and population density determine different prevalence rates, typically lower in rural areas, possibly due to natural social distancing or limited interaction with people at risk.

Idioma originalInglés estadounidense
-100131
PublicaciónGlobal Epidemiology
Volumen7
DOI
EstadoIndizado - jun. 2024

Nota bibliográfica

Publisher Copyright:
© 2023

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

  1. ODS 3: Salud y bienestar
    ODS 3: Salud y bienestar

Huella

Profundice en los temas de investigación de 'Differences in SARS-COV-2 seroprevalence in the population of Cusco, Peru'. En conjunto forman una huella única.

Citar esto